"I notice you have this as not held. What's holding you back from buying a share of this company?"
In a word, valuation.
I did own the stock at stages over the course of 2023, but it hasn't been a high conviction position. As a result, it has been a "trade" for me which, while profitable, is not in keeping with my investing DNA which is more aligned with being a long-term holder of rapid-growth compounders. Or, when opportunity presents, a buyer of cyclical businesses trading at very steep discounts to intrinsic valuation.
I don't think SHL is either of these.
But there are times when it does succumb to the market schitzophrenia from being overly loved to being overly hated. Which is why I maintain a watch on the business, but it's never represented elegant investing in my mind, because the times I have made sh0rt-term money out of it, I feel it involved too much luck for my liking.
Don't get me wrong; it isn't a cruddy company. It's a resilient business model, with granular customer base and stable recurring earnings [*], and is more than ably stewarded by its directors.
It's just that it isn't a nimble ski-boat that is capable of rapid acceleration (instead, it's more like a slow-moving oil tanker... slower than the ski boat, maybe, but a lot harder to sink); nor is it ever priced at bargain basement levels that permits having a big, red-hot conviction go at it.
[*] In this same pathology space, I did spend a few hours the other week looking at a minnow in the industry [https://hotcopper.com.au/posts/72281791/single], which looks a lot cheaper than SHL, but the trade-off is that it lacks the long track record of SHL,
.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
SHL
sonic healthcare limited
Add to My Watchlist
1.15%
!
$27.16

"I notice you have this as not held. What's holding you back...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$27.16 |
Change
0.310(1.15%) |
Mkt cap ! $13.42B |
Open | High | Low | Value | Volume |
$26.99 | $27.50 | $26.80 | $22.89M | 842.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 620 | $27.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$27.17 | 23 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 27.140 |
1 | 85 | 27.100 |
2 | 838 | 27.090 |
1 | 1031 | 26.990 |
1 | 370 | 26.950 |
Price($) | Vol. | No. |
---|---|---|
27.240 | 838 | 2 |
27.320 | 735 | 1 |
27.400 | 5000 | 1 |
27.480 | 1770 | 1 |
27.490 | 4000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SHL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online